📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial. (2020)

First Author: Clarke E

Attributed to: IMPRINT: IMmunising PRegnant women and INfants neTwork funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2019.08.072

PubMed Identifier: 31843266

Publication URI: http://europepmc.org/abstract/MED/31843266

Type: Journal Article/Review

Volume: 38

Parent Publication: Vaccine

Issue: 2

ISSN: 0264-410X